HAEMOGLOBIN WITH VITAMIN B12

This brand name is authorized in Nigeria.

Active ingredients

The drug HAEMOGLOBIN WITH VITAMIN B12 contains a combination of these active pharmaceutical ingredients (APIs):

1	Haemoglobin UNII VSU9IB86SP - HEMOGLOBIN
2	Vitamin B12 UNII P6YC3EG204 - CYANOCOBALAMIN
	Hydroxocobalamin is used in the treatment and prevention of Vitamin B12 deficiency. For adults, the daily requirement of Vitamin B12 is probably about 1 to 2 micrograms and this amount is present in most normal diets. However, Vitamin B12 only occurs in animal products, not in vegetables, and therefore strict vegetarian or vegan diets that exclude dairy products may provide an inadequate amount, although a deficiency may not be apparent for many years.
	Read more about Vitamin B12

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-3816	Syrup	Vamis Syrup of Heamoglobin SYRUP 16% 1 x 200 mL, 1 x 300 mL (in amber bottles)	Oral Liquid A reddish brown syrup with characteristic odor in an amber bottle RNW-PP-323516 VAMI'S SYRUP OF HEAMOGLOBIN HEAMOGBLOBIN , LIVER EXTRACT OR ORAL USE, CYANOCOBOLAMIN HEAMOGLOBIN 16.0 W/V, LIVER EXTRACT FOR ORAL USE 3.1G W/V, CYANOCOBOLAMIN 100NG W/V, TINCTURE OF BITTER ORANGE PEEL 4.6 W/V Apr-16 Drugs BLOOD AND BLOOD FORMING ORGANS Nigerian Products 200ML, 300ML OTC 5/5/2023 TUYIL PHARMACEUTICAL INDUSTRIES LTD, , M.M WAY ILORIN KWARA 8033565739 tuyilpharma18@gmail.com Tuyil Pharmaceutical Industries Limited, 22, New Yidi Road, Ilorin, Kwara State., Nigeria	30/04/2024
04-7309	Liquid	Ayrtons Syrup of Haemoglobin with Vitamin B12 LIQ 20 mcg/5 mL; 500 mg/5 mL	Liquid	10/11/2020
A11-100042	Syrup	Nalis Hb 12 SYRUP 5% 1 x 200 mL (in HDPE bottle)	Syrup 924 Hermoglobin Syrup With B12 A11-100042 Nalis Hb 12 Each Contains:Haemoglobin W/V,Liver Extract For Oral Use . W/V,Cyanocobalamine (Vitamin B) W/V,Excipients Qs Ml Blood Products And Drugs Affecting The Blood -- Select -- 5ml,5.0 % W/V, 3.1 % W/V,0.0001% W/V,100ml Syrup Over The Counter (Otc) Nalis Pharmaceuticals Limited Nalis Pharmaceuticals Limited Nigeria 2021-03-29 2026-03-28	29/03/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A11AA01	Multivitamins and iron	A Alimentary tract and metabolism → A11 Vitamins → A11A Multivitamins, combinations → A11AA Multivitamins with minerals
Discover more medicines within A11AA01
B03AE01	Iron, vitamin B12 and folic acid	B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations → B03AE Iron in other combinations
Discover more medicines within B03AE01
B03BA51	Cyanocobalamin, combinations	B Blood and blood forming organs → B03 Antianemic preparations → B03B Vitamin B12 and folic acid → B03BA Vitamin B12 (cyanocobalamin and analogues)
Discover more medicines within B03BA51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-3816, 04-7309, A11-100042